France’s Sanofi to help Johnson & Johnson manufacture COVID-19 vaccine

PARIS (Reuters) – French healthcare company Sanofi will provide COVID-19 vaccine manufacturing support to U.S. peer Johnson & Johnson, Sanofi said on Monday.

Once authorized, Sanofi will provide Johnson & Johnson access to the established infrastructure and expertise of its vaccine manufacturing plant in Marcy l’Etoile, France, to formulate and fill vials of Johnson & Johnson’s Janssen COVID-19 vaccine candidate in 2021 at a rate of approximately 12 million doses per month.

FILE PHOTO: FILE PHOTO: A Sanofi logo is seen during the company’s annual results news conference in Paris, France, February 6, 2020. REUTERS/Benoit Tessier


Reporting by Sudip Kar-Gupta; editing by Jason Neely

Reuters source: